Key data from the 2022 European Thyroid Association Congress. Role of molecular biology in aggressive thyroid cancer
Annales d'Endocrinologie · 2023
DOI: 10.1016/j.ando.2023.05.003 ↗Kurz gefasst
Leserbrief in der Zeitschrift Annales d'Endocrinologie, 2023. Verfasst von Magalie Haissaguerre und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Endocrine Oncology, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Endocrine Oncology, Haut-Lévêque Hospital, Bordeaux University Hospital, Pessac, France.
- Department of Endocrinology, Metabolic Diseases and Nutrition, Cardiovascular and Metabolic Unit, CHU of Larrey, 24, chemin de Pouvourville, TSA 30030, 31059 Toulouse cedex, France. Electronic address: caron.p@chu-toulo…
Zitieren
APA
Haissaguerre, M., & Caron, P. (2023). Key data from the 2022 European Thyroid Association Congress. Role of molecular biology in aggressive thyroid cancer. Annales d'Endocrinologie. https://doi.org/10.1016/j.ando.2023.05.003
Vancouver
Haissaguerre M, Caron P. Key data from the 2022 European Thyroid Association Congress. Role of molecular biology in aggressive thyroid cancer. Annales d'Endocrinologie. 2023. doi:10.1016/j.ando.2023.05.003
BibTeX
@article{Haissaguerre2023,
author = {Haissaguerre, Magalie and Caron, Philippe},
title = {Key data from the 2022 European Thyroid Association Congress. Role of molecular biology in aggressive thyroid cancer},
journal = {Annales d'Endocrinologie},
year = {2023},
doi = {10.1016/j.ando.2023.05.003}
}
EUVIMED